These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 25566497)
1. Pharmacological doses of daily ascorbate protect tumors from radiation damage after a single dose of radiation in an intracranial mouse glioma model. Grasso C; Fabre MS; Collis SV; Castro ML; Field CS; Schleich N; McConnell MJ; Herst PM Front Oncol; 2014; 4():356. PubMed ID: 25566497 [TBL] [Abstract][Full Text] [Related]
2. Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific. Castro ML; McConnell MJ; Herst PM Free Radic Biol Med; 2014 Sep; 74():200-9. PubMed ID: 24992837 [TBL] [Abstract][Full Text] [Related]
3. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. Newcomb EW; Demaria S; Lukyanov Y; Shao Y; Schnee T; Kawashima N; Lan L; Dewyngaert JK; Zagzag D; McBride WH; Formenti SC Clin Cancer Res; 2006 Aug; 12(15):4730-7. PubMed ID: 16899624 [TBL] [Abstract][Full Text] [Related]
4. Implantable polymers for tirapazamine treatments of experimental intracranial malignant glioma. Yuan X; Tabassi K; Williams JA Radiat Oncol Investig; 1999; 7(4):218-30. PubMed ID: 10492162 [TBL] [Abstract][Full Text] [Related]
5. Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas. Abdelwahab MG; Sankar T; Preul MC; Scheck AC J Vis Exp; 2011 Nov; (57):e3403. PubMed ID: 22158303 [TBL] [Abstract][Full Text] [Related]
6. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide. Ning S; Knox SJ Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556 [TBL] [Abstract][Full Text] [Related]
9. STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma. Geng L; Shinohara ET; Kim D; Tan J; Osusky K; Shyr Y; Hallahan DE Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):263-71. PubMed ID: 16274936 [TBL] [Abstract][Full Text] [Related]
10. Protracted exposure radiosensitization of experimental human malignant glioma. Williams JA; Williams JR; Yuan X; Dillehay LE Radiat Oncol Investig; 1998; 6(6):255-63. PubMed ID: 9885941 [TBL] [Abstract][Full Text] [Related]
11. A new anti-glioma therapy, AG119: pre-clinical assessment in a mouse GL261 glioma model. Towner RA; Ihnat M; Saunders D; Bastian A; Smith N; Pavana RK; Gangjee A BMC Cancer; 2015 Jul; 15():522. PubMed ID: 26177924 [TBL] [Abstract][Full Text] [Related]
12. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine. Halperin EC; Brizel DM; Honore G; Sontag MR; Griffith OW; Bigner DD; Friedman HS Int J Radiat Oncol Biol Phys; 1992; 24(1):103-9. PubMed ID: 1512145 [TBL] [Abstract][Full Text] [Related]
13. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics. Elmore AR Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915 [TBL] [Abstract][Full Text] [Related]
14. Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines. Bhave SR; Dadey DY; Karvas RM; Ferraro DJ; Kotipatruni RP; Jaboin JJ; Hallahan AN; Dewees TA; Linkous AG; Hallahan DE; Thotala D Front Oncol; 2013; 3():236. PubMed ID: 24062988 [TBL] [Abstract][Full Text] [Related]
15. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02. Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540 [TBL] [Abstract][Full Text] [Related]
16. Synthetic, implantable polymers for IUdR radiosensitization of experimental human malignant glioma. Yuan X; Dillehay LE; Williams JR; Williams JA Cancer Biother Radiopharm; 1999 Jun; 14(3):187-202. PubMed ID: 10850303 [TBL] [Abstract][Full Text] [Related]
17. Convection-enhanced delivery of temozolomide and whole cell tumor immunizations in GL261 and KR158 experimental mouse gliomas. Enríquez Pérez J; Kopecky J; Visse E; Darabi A; Siesjö P BMC Cancer; 2020 Jan; 20(1):7. PubMed ID: 31900109 [TBL] [Abstract][Full Text] [Related]
19. No role of IFITM3 in brain tumor formation in vivo. Stankovic ND; Hoppmann N; Teodorczyk M; Kim EL; Bros M; Giese A; Zipp F; Schmidt MHH Oncotarget; 2016 Dec; 7(52):86388-86405. PubMed ID: 27835870 [TBL] [Abstract][Full Text] [Related]
20. Intratumoral delivery of bortezomib: impact on survival in an intracranial glioma tumor model. Wang W; Cho HY; Rosenstein-Sisson R; Marín Ramos NI; Price R; Hurth K; Schönthal AH; Hofman FM; Chen TC J Neurosurg; 2018 Mar; 128(3):695-700. PubMed ID: 28409734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]